Navigation Links
Bix of Sanders-Brown receives NIH funding for stroke research
Date:5/12/2013

LEXINGTON, Ky. (May 13, 2013) Dr. Gregory Bix, Paul G. Blazer J. Professor of Stroke Research in the University of Kentucky Sanders-Brown Center on Aging and the UK departments of Anatomy and Neurobiology and Neurology, has received funding of $224,416 from the National Institutes of Health, to further study of stroke recovery.

Stroke is a leading cause of death in the U.S. and worldwide. Existing FDA-approved pharmaceutical therapies for stroke rely upon administration within a very tight timeframe, and engender other risks. Dr. Bix is working to investigate how the brain's own neuroprotective abilities may be employed to activate post-stroke repair mechanisms in the brain itself.

"This research grant provides the financial support for us to explore promising new approaches to cure stroke through unlocking the brain's regenerative potential. Successful completion of this basic research will bring us that much closer to hopefully successful human clinical trials for stroke sufferers, something that has otherwise been an elusive goal" said Bix.

The new funding from the NIH will enable Bix and his team to investigate the effects of a newly identified stroke treatment on brain tissue regeneration, to investigate factors influencing generation and survival of post-stroke generated neurons, and to investigate novel mechanisms in neuritogenesis and neurite extension. The ultimate aim of this work is to develop a novel stroke therapy for humans.


'/>"/>

Contact: Allison Elliott
allison.elliott@uky.edu
University of Kentucky
Source:Eurekalert

Page: 1

Related medicine news :

1. QuickMedical Receives Veteran Owned Small Business Verification
2. GW receives Patient-Centered Outcomes Research Institute award to evaluate cancer survivorship care
3. Presence Technology Receives 2013 Unified Communications TMC Labs Innovation Award
4. Newest MEDSEEK Patient Portal Receives Meaningful Use Certification
5. GuardRFID’s Argus AllGuard Active RFID Platform Receives Lenel Factory Certification Under Lenel’s OpenAccess Alliance Program
6. Cleveland Clinic receives $2 million to endow Chair in colorectal surgery
7. Beaumont receives national green award
8. Alzheimer's Treatment Clinical Trial Receives Clearance
9. Princeton Ivy Capital Advisors LLC Receives #1 Rank According to Money Manager Review (MMR is an Independent Third Party Ranking Authority) for Large Cap Core Managers
10. GuardRFID’s Active RFID Tag Reader Receives Lenel Factory Certification for its OSDP Interface to OnGuard 2012 (6.5) and OnGuard 2013 (6.6)
11. Viewpoints TV Area Receives Grade A from American Lung Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: